An, I think if you and Paul were prepared ahead of time for what would happen, it might have been easier. You know, having to relive the expereince so deeply was bound to take its toll. It's not like you could write a few pages and walk away. I hope the interviewer was nice to you. Also, I hope you will have the opportunity to rest - and relax!
Alf, your post had me laughing! I had some dental work done and am missing a few teeth. I couldn't say all those things - and public speaking doesn't really scare me. However, doing what An did might cause me to shake in my boots!
Ron wasn't a participant in the study. Looking back now, I wish he had been. Here's some information:
Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial
The Prostate, Lung, Colorectal and Ovarian Cancer
Screening Trial, or PLCO, is a National Institutes of Health (NIH)/National
Cancer Institute (NCI)-funded large-scale clinical trial to determine whether
certain cancer screening tests reduce deaths from prostate, lung, colorectal and
ovarian cancer. In addition, there are numerous epidemiologic and ancillary
studies going on that will answer other crucial questions about these cancers
and these screening tests.
Dr. Gerald L. Andriole is the principal investigator for Washington
University PLCO in addition to being the Robert K. Royce Distinguished Professor
of Urologic Surgery and chief of the Division of Urologic Surgery. He is also
chairman of the Prostate Committee for PLCO and on the NCI’s Advisory Board for
the PLCO Biorepository.
More than 154,000 women and men joined the PLCO trial between 1992 and 2001
at 10 centers across the country. These participants were between the ages of 55
and 74 when they joined. Half of these participants were selected by chance to
receive specific screening tests and half receive routine care by their personal
health care providers. All participants provide regular updates on a variety of
health measurements in an annual questionnaire, as well as blood samples for use
in studies of biologic markers of cancer risk from the screened group.
Prostate, lung, colorectal and ovarian cancers account for more than 48
percent of all cancers diagnosed and 49 percent of all cancer deaths in the
United States. about 255,600 people will die from these cancers this year.
PLCO is sponsored and run by the National Cancer Institute, one of the
National Institutes of Health and part of the U.S. Public Health Service.
Post Edited (Aimzee) : 11/29/2011 7:11:55 AM (GMT-7)